BDRX — Biodexa Pharmaceuticals Plc
Fresh Supply424B filed ~14d ago🌀 Serial Splitter📄 Fresh Paper1-for-62,509 cumulative
424B filed ~14d ago
Case Notes
Biodexa Pharmaceuticals Plc has 4 reverse splits on record — cumulative 1-for-62,509. No twelve-month share-count comparison is available in the XBRL record.
No stress-language filings on record in our dataset. However, 8 supply registrations (S-1/424B) appear in the last 12 months.
Registered shares exist to be sold — that is what the S-1 and 424B instruments document. In our research across this filing posture, freshly registered supply is the loaded state of the cycle: the paperwork has created the legal right to place shares into the market. That is not a prediction — it is what the filings say is possible.
Share Count Over Time
XBRL cover-page share counts from SEC EDGAR filings. Amber dashed lines mark reverse-split dates. 4 reverse splits on record.
Reverse Split Log
Each event consolidates shares — fewer shares, same market cap. Source: EDGAR corporate actions.
Cumulative effective ratio: 1-for-62,509— a share held at inception is now worth 1/62,509 of its original fraction.
424B Supply Pulse
Prospectus supplements (424B5) filed registering shares for resale — each bar is one month with a filing. Bars above average signal active distribution windows. Source: SEC EDGAR.